TABLE III.
Characteristic | Strengths | Potential weaknesses |
---|---|---|
Study design | ||
Cohort | • Prospective • Multiple outcomes |
• Limited statistical power for specific birth defects • More costly |
Case-control | • Multiple exposures • Statistical power for specific birth defects • Less costly |
• Retrospective • Limited statistical power for infrequent exposures |
Database | • Prospective • Population-based • Multiple exposures • Multiple outcomes • Statistical power for groups of defects possible • May be least costly |
|
Medication exposure capture | ||
Cohort | • Data captured on medication as actually taken • Data captured on OTC medications (including vitamins) • Data captured on borrowed medication |
|
Case-control | • Data captured on medication as actually taken • Data captured on OTC medications (including vitamins) • Data captured on borrowed medication |
• Retrospective exposure information |
Database | • Medication prescribed may not be taken • Timing of exposure estimated when gestational age is not captured |
|
Bias and confounding | ||
Cohort | • Outcomes confirmed by interview and medical records • Data available on confounders, eg, alcohol, tobacco, and folic acid use |
• Potential volunteer bias |
Case-control | • Outcomes confirmed by interview and medical records • Data available on confounders, eg, alcohol, tobacco, and folic acid use |
• Potential volunteer bias • Potential recall bias • Potential biased control selection |
Database | • No selection bias • Diagnoses in pregnancy losses rarely captured |
• Data not available for some key confounders, eg body mass index |
OTC, Over-the-counter.